Startup investors — January 2026 · Jan 1, 2026 – Jan 31, 2026

Investor activity and startup funding rounds for the selected month.

151

Innovation IndustriesLatest Jan 20

Orbem · €55.5M Series B ViCentra · $13M Series D

2rounds

—led

AI 1Healthtech 1

Series B 1, Series C+ 1

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Orbem €55.5M Series B ViCentra $13M Series D

152

Modi VenturesLatest Jan 20

Exciva · €51M Series B Proxima · $80M Undisclosed

2rounds

—led

Biotech 2

Series B 1, Undisclosed 1

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Exciva €51M Series B Proxima $80M Undisclosed

153

Oncology VenturesLatest Jan 20

BIOMAKERS · $8M Undisclosed RISA Labs · $11.1M Series A

2rounds

—led

AI 1Biotech 1

Series A 1, Undisclosed 1

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

BIOMAKERS $8M Undisclosed RISA Labs $11.1M Series A

154

Opera Tech VenturesLatest Jan 20

Stoïk · €20M Series C Alpaca · $150M Series D

2rounds

0led

Fintech 2

Series C+ 2

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Stoïk €20M Series C Alpaca $150M Series D

155

Possible VenturesLatest Jan 20

Orbem · €55.5M Series B Transition Metal Solutions · $6M Seed

2rounds

—led

AI 1Industrial tech 1

Seed 1, Series B 1

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series B 1

Orbem €55.5M Series B Transition Metal Solutions $6M Seed

156

Supernova InvestLatest Jan 20

Orbem · €55.5M Series B Spiro Medical · $67M Series A

2rounds

—led

AI 1Healthtech 1

Series A 1, Series B 1

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Orbem €55.5M Series B Spiro Medical $67M Series A

157

Uncork CapitalLatest Jan 20

Ivo · $55M Series B Quadric · $30M Series C

2rounds

0led

AI 1Enterprise software 1

Series B 1, Series C+ 1

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Ivo $55M Series B Quadric $30M Series C

158

YK BioventuresLatest Jan 20

Think Bioscience · $55M Series A Vivere Oncotherapies · $10M Series A

2rounds

—led

Biotech 2

Series A 2

Jan 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Think Bioscience $55M Series A Vivere Oncotherapies $10M Series A

159

GeorgianLatest Jan 19

Dominion Dynamics · $15.2M Seed Cyera · $400M Series F

2rounds

—led

Cybersecurity 1Defense tech 1

Seed 1, Series C+ 1

Jan 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Dominion Dynamics $15.2M Seed Cyera $400M Series F

160

Inc.Latest Jan 16

ClickHouse · $400M Series D Mirador Therapeutics · $250M Series B

2rounds

—led

Biotech 1Developer tools 1

Series B 1, Series C+ 1

Jan 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

ClickHouse $400M Series D Mirador Therapeutics $250M Series B

161

Altimeter CapitalLatest Jan 15

Parloa · $350M Series D Hadrian · Undisclosed Undisclosed

2rounds

—led

Enterprise software 1Industrial tech 1

Series C+ 1, Undisclosed 1

Jan 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Parloa $350M Series D Hadrian Undisclosed Undisclosed

162

Durable Capital PartnersLatest Jan 15

Parloa · $350M Series D VieCure · $43M Undisclosed

2rounds

—led

Enterprise software 1Healthtech 1

Series C+ 1, Undisclosed 1

Jan 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Parloa $350M Series D VieCure $43M Undisclosed

163

GreenoaksLatest Jan 15

Mytra · $120M Series C Cyera · $400M Series F

2rounds

—led

Cybersecurity 1Robotics 1

Series C+ 2

Jan 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Mytra $120M Series C Cyera $400M Series F

164

PayPal VenturesLatest Jan 15

Pinch AI · $5M Seed Klearly · €12M Series A

2rounds

—led

Ecommerce 1Fintech 1

Seed 1, Series A 1

Jan 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Pinch AI $5M Seed Klearly €12M Series A

165

SOSVLatest Jan 15

Sable · Undisclosed Pre-Seed Transition Metal Solutions · $6M Seed

2rounds

—led

Biotech 1Industrial tech 1

Pre-seed 1, Seed 1

Jan 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Seed 1

Sable Undisclosed Pre-Seed Transition Metal Solutions $6M Seed

166

Commerce VenturesLatest Jan 14

Monnai · $12M Equity WeatherPromise · $12.8M Series A

2rounds

—led

Fintech 1Travel tech 1

Series A 1, Undisclosed 1

Jan 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Monnai $12M Equity WeatherPromise $12.8M Series A

167

Fin CapitalLatest Jan 14

Project Eleven · $20M Series A WitnessAI · $58M Strategic

2rounds

—led

Cybersecurity 1Fintech 1

Series A 1, Undisclosed 1

Jan 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Project Eleven $20M Series A WitnessAI $58M Strategic

168

Link VenturesLatest Jan 14

VoiceRun · $5.5M Seed Presto Phoenix · $10M Undisclosed

2rounds

—led

AI 1Foodtech 1

Seed 1, Undisclosed 1

Jan 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

VoiceRun $5.5M Seed Presto Phoenix $10M Undisclosed

169

Omega FundsLatest Jan 14

Caldera Therapeutics · $37.5M Series A1 Spiro Medical · $67M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 2

Jan 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Caldera Therapeutics $37.5M Series A1 Spiro Medical $67M Series A

170

PortageLatest Jan 14

Alpaca · $150M Series D Pluto Financial Technologies · $8.6M Seed

2rounds

0led

Fintech 2

Seed 1, Series C+ 1

Jan 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Alpaca $150M Series D Pluto Financial Technologies $8.6M Seed

171

Samsung VenturesLatest Jan 14

Amperon · Undisclosed Undisclosed WitnessAI · $58M Strategic

2rounds

—led

Climate tech 1Cybersecurity 1

Undisclosed 2

Jan 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

Amperon Undisclosed Undisclosed WitnessAI $58M Strategic

172

Francisco PartnersLatest Jan 13

StarLIMS · Undisclosed Undisclosed Avalon Healthcare Solutions · Undisclosed Undisclosed

2rounds

—led

Enterprise software 1Healthtech 1

Undisclosed 2

Jan 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

StarLIMS Undisclosed Undisclosed Avalon Healthcare Solutions Undisclosed Undisclosed

173

MadronaLatest Jan 13

Deepgram · $130M Series C Spangle AI · $15M Series A

2rounds

—led

AI 2

Series A 1, Series C+ 1

Jan 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Deepgram $130M Series C Spangle AI $15M Series A

174

Saras CapitalLatest Jan 13

Converge Bio · $25M Series A Biographica · £7M Undisclosed

2rounds

—led

Agritech 1AI 1

Series A 1, Undisclosed 1

Jan 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Converge Bio $25M Series A Biographica £7M Undisclosed

175

Farallon Capital ManagementLatest Jan 12

Mirador Therapeutics · $250M Series B Parabilis Medicines · $305M Series F

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jan 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Mirador Therapeutics $250M Series B Parabilis Medicines $305M Series F

176

HSGLatest Jan 12

Vibrant Therapeutics · $61M Series A Spiro Medical · $67M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 2

Jan 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Vibrant Therapeutics $61M Series A Spiro Medical $67M Series A

177

InvusLatest Jan 12

Mirador Therapeutics · $250M Series B Parabilis Medicines · $305M Series F

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jan 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Mirador Therapeutics $250M Series B Parabilis Medicines $305M Series F

178

Northern Light Venture CapitalLatest Jan 12

Vibrant Therapeutics · $61M Series A Spiro Medical · $67M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 2

Jan 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Vibrant Therapeutics $61M Series A Spiro Medical $67M Series A

179

Northpond VenturesLatest Jan 12

VieCure · $43M Undisclosed Vizgen · $48M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 1, Undisclosed 1

Jan 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

VieCure $43M Undisclosed Vizgen $48M Series A

180

RA Capital ManagementLatest Jan 10

Kinaset Therapeutics · $103M Series B Parabilis Medicines · $305M Series F

2rounds

—led

Biotech 2

Series B 1, Series C+ 1

Jan 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Kinaset Therapeutics $103M Series B Parabilis Medicines $305M Series F

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.